{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:01:14Z","timestamp":1791169274948,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T00:00:00Z","timestamp":1233619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/cr.2009.12","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T11:40:22Z","timestamp":1233661222000},"page":"574-583","source":"Crossref","is-referenced-by-count":23,"title":["Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes"],"prefix":"10.1038","volume":"19","author":[{"given":"Guoliang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwu Z","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Qin","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,3]]},"reference":[{"key":"BFcr200912_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJM198708133170703","volume":"317","author":"MB Bornstein","year":"1987","unstructured":"Bornstein MB, Miller A, Slagle S, et al. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 1987; 317:408\u2013414.","journal-title":"N Engl J Med"},{"key":"BFcr200912_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1073\/pnas.89.1.137","volume":"89","author":"D Teitelbaum","year":"1992","unstructured":"Teitelbaum D, Milo R, Arnon R, Sela M . Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. Proc Natl Acad Sci USA 1992; 89:137\u2013141.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr200912_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1037\/0003-066X.55.11.1304","volume":"55","author":"MB Canter","year":"2000","unstructured":"Canter MB . Reflections on receiving an award. Am Psychol 2000; 55:1304\u20131311.","journal-title":"Am Psychol"},{"key":"BFcr200912_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-5728(99)00239-8","volume":"103","author":"M Zhang","year":"2000","unstructured":"Zhang M, Chan CC, Vistica B, Hung V, Wiggert B, Gery I . Copolymer 1 inhibits experimental autoimmune uveoretinitis. J Neuroimmunol 2000; 103:189\u2013194.","journal-title":"J Neuroimmunol"},{"issue":"Suppl 2","key":"BFcr200912_CR5","doi-asserted-by":"publisher","first-page":"14593","DOI":"10.1073\/pnas.0404887101","volume":"101","author":"R Arnon","year":"2004","unstructured":"Arnon R, Aharoni R . Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci USA 2004; 101 (Suppl 2):14593\u201314598.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr200912_CR6","doi-asserted-by":"publisher","first-page":"G628","DOI":"10.1152\/ajpgi.00137.2006","volume":"292","author":"A Horani","year":"2007","unstructured":"Horani A, Muhanna N, Pappo O, et al. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 292:G628\u2013G638.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFcr200912_CR7","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1073\/pnas.91.11.4872","volume":"91","author":"M Fridkis-Hareli","year":"1994","unstructured":"Fridkis-Hareli M, Teitelbaum D, Gurevich E, et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells \u2013 specificity and promiscuity. Proc Natl Acad Sci USA 1994; 91:4872\u20134876.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr200912_CR8","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.4049\/jimmunol.170.9.4483","volume":"170","author":"PL Vieira","year":"2003","unstructured":"Vieira PL, Heystek HC, Wormmeester J, Wierenga EA, Kapsenberg ML . Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J Immunol 2003; 170:4483\u20134488.","journal-title":"J Immunol"},{"key":"BFcr200912_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nm1620","volume":"13","author":"MS Weber","year":"2007","unstructured":"Weber MS, Prod'homme T, Youssef S, et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 2007; 13:935\u2013943.","journal-title":"Nat Med"},{"key":"BFcr200912_CR10","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.4049\/jimmunol.177.4.2167","volume":"177","author":"F Billiard","year":"2006","unstructured":"Billiard F, Litvinova E, Saadoun D, et al. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J Immunol 2006; 177:2167\u20132174.","journal-title":"J Immunol"},{"key":"BFcr200912_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1196\/annals.1361.048","volume":"1051","author":"CA Piccirillo","year":"2005","unstructured":"Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V . Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann N Y Acad Sci 2005; 1051:72\u201387.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcr200912_CR12","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1172\/JCI28941","volume":"116","author":"M Vukmanovic-Stejic","year":"2006","unstructured":"Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116:2423\u20132433.","journal-title":"J Clin Invest"},{"key":"BFcr200912_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68\u201373.","journal-title":"Nat Genet"},{"key":"BFcr200912_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057\u20131061.","journal-title":"Science"},{"key":"BFcr200912_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330\u2013336.","journal-title":"Nat Immunol"},{"key":"BFcr200912_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F . An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337\u2013342.","journal-title":"Nat Immunol"},{"key":"BFcr200912_CR17","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1073\/pnas.0502187102","volume":"102","author":"J Hong","year":"2005","unstructured":"Hong J, Li N, Zhang X, Zheng B, Zhang JZ . Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci USA 2005; 102:6449\u20136454.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr200912_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clim.2007.05.020","volume":"125","author":"Y Jee","year":"2007","unstructured":"Jee Y, Piao WH, Liu R, et al. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin Immunol 2007; 125:34\u201342.","journal-title":"Clin Immunol"},{"key":"BFcr200912_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","volume":"85","author":"R Tisch","year":"1996","unstructured":"Tisch R, McDevitt H . Insulin-dependent diabetes mellitus. Cell 1996; 85:291\u2013297.","journal-title":"Cell"},{"key":"BFcr200912_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0889-8529(01)00017-2","volume":"31","author":"E Liu","year":"2002","unstructured":"Liu E, Eisenbarth GS . Type 1A diabetes mellitus-associated autoimmunity. Endocrinol Metab Clin North Am 2002; 31:391\u2013410, vii\u2013viii.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFcr200912_CR21","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1073\/pnas.96.7.3333","volume":"96","author":"HL Weiner","year":"1999","unstructured":"Weiner HL . Oral tolerance with copolymer 1 for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1999; 96:3333\u20133335.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr200912_CR22","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.4049\/jimmunol.177.10.6603","volume":"177","author":"S Brode","year":"2006","unstructured":"Brode S, Raine T, Zaccone P, Cooke A . Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2006; 177:6603\u20136612.","journal-title":"J Immunol"},{"key":"BFcr200912_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon B, Lenschow DJ, Rhee L, et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12:431\u2013440.","journal-title":"Immunity"},{"key":"BFcr200912_CR24","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","volume":"171","author":"S Gregori","year":"2003","unstructured":"Gregori S, Giarratana N, Smiroldo S, Adorini L . Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003; 171:4040\u20134047.","journal-title":"J Immunol"},{"key":"BFcr200912_CR25","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/eji.200425274","volume":"34","author":"M de la Rosa","year":"2004","unstructured":"de la Rosa M, Rutz S, Dorninger H, Scheffold A . Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34:2480\u20132488.","journal-title":"Eur J Immunol"},{"key":"BFcr200912_CR26","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","volume":"172","author":"AM Thornton","year":"2004","unstructured":"Thornton AM, Donovan EE, Piccirillo CA, Shevach EM . Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004; 172:6519\u20136523.","journal-title":"J Immunol"},{"key":"BFcr200912_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/eji.200324455","volume":"34","author":"AM Thornton","year":"2004","unstructured":"Thornton AM, Piccirillo CA, Shevach EM . Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 2004; 34:366\u2013376.","journal-title":"Eur J Immunol"},{"key":"BFcr200912_CR28","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875\u20131886.","journal-title":"J Exp Med"},{"key":"BFcr200912_CR29","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","volume":"172","author":"MC Fantini","year":"2004","unstructured":"Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF . Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149\u20135153.","journal-title":"J Immunol"},{"key":"BFcr200912_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1084\/jem.20042276","volume":"201","author":"JC Marie","year":"2005","unstructured":"Marie JC, Letterio JJ, Gavin M, Rudensky AY . TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005; 201:1061\u20131067.","journal-title":"J Exp Med"},{"key":"BFcr200912_CR31","first-page":"2434","volume":"116","author":"Z Wang","year":"2006","unstructured":"Wang Z, Hong J, Sun W, et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25\u2212 T cells to CD4+ Tregs. J Clin Invest 2006; 116:2434\u20132441.","journal-title":"J Clin Invest"},{"key":"BFcr200912_CR32","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.4049\/jimmunol.175.9.6107","volume":"175","author":"A Skapenko","year":"2005","unstructured":"Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H . The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol 2005; 175:6107\u20136116.","journal-title":"J Immunol"},{"key":"BFcr200912_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jaut.2005.04.001","volume":"25","author":"P Maerten","year":"2005","unstructured":"Maerten P, Shen C, Bullens DM, et al. Effects of interleukin 4 on CD25+CD4+ regulatory T cell function. J Autoimmun 2005; 25:112\u2013120.","journal-title":"J Autoimmun"},{"key":"BFcr200912_CR34","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1073\/pnas.1131954100","volume":"100","author":"EE Hamilton-Williams","year":"2003","unstructured":"Hamilton-Williams EE, Palmer SE, Charlton B, Slattery RM . Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci USA 2003; 100:6688\u20136693.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr200912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr200912","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr200912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:26:13Z","timestamp":1684416373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr200912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,3]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFcr200912"],"URL":"https:\/\/doi.org\/10.1038\/cr.2009.12","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,3]]}}}